GeneDx Holdings Corp. (WGS) — Financial Flexibility Index
GeneDx Holdings Corp. (WGS) has a Financial Flexibility Index of -0.10x as of March 2026. Free cash flow of $-25.95 Million (operating CF $-32.41 Million minus capex $6.45 Million) represents 0% of total liabilities ($252.18 Million). Also explore GeneDx Holdings Corp. equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GeneDx Holdings Corp. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for GeneDx Holdings Corp. across 6 annual periods. Check WGS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GeneDx Holdings Corp. (2020–2025)
Year-by-year free cash flow to debt coverage for GeneDx Holdings Corp.. For the full company profile including market capitalisation, see WGS market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | $52.30 Million | $33.28 Million | $262.01 Million | ▲ +251.1% |
| 2024 | -0.13x | $-23.00 Million | $-28.50 Million | $174.13 Million | ▲ +85.6% |
| 2023 | -0.91x | $-174.44 Million | $-180.15 Million | $190.74 Million | ▲ +12.5% |
| 2022 | -1.05x | $-304.83 Million | $-319.15 Million | $291.56 Million | ▼ -2.3% |
| 2021 | -1.02x | $-169.65 Million | $-190.43 Million | $165.99 Million | ▼ -313.2% |
| 2020 | -0.25x | $-61.15 Million | $-93.13 Million | $247.25 Million | — |